TFF Pharmaceuticals, Inc.
TFFPDelisted Mar 6, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001733413
TFF Pharmaceuticals, Inc. was delisted on Mar 6, 2025; its insiders filed their last Form 4 on Jul 8, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $1.48M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TFF Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TFF Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Rocamboli Stephen | Director | 39,165 | Jul 8, 2024 | 0 |
| Mills Robert S | Director | 59,145 | Jul 8, 2024 | 0 |
| King Thomas Braxton | Director | 1,583 | Jul 8, 2024 | 0 |
| Roberts Brandi | Director | 23,165 | Jul 8, 2024 | 0 |
| Lee Catherine Chai-zon | Director | 1,583 | Jul 8, 2024 | 0 |
| Weisman Harlan F | President and CEO | 842,095 | Jul 8, 2024 | 0 |
| Coleman Kirk Allen | Chief Financial Officer | 45,859 | Jul 8, 2024 | 0 |
| Mikhak Zamaneh | Chief Medical Officer | 145,184 | Jul 8, 2024 | 0 |
| Patane Michael A | Director | – | Apr 22, 2024 | 0 |
| Carlson Capital, L.P. | 10% Owner | 5,064,000Indirect | Aug 17, 2023 | 0 |
| Carlson Clint Duane | 10% Owner | 5,064,000Indirect | Aug 17, 2023 | 0 |
| Double Black Diamond Offshore Ltd | 10% Owner | 5,064,000Indirect | Aug 17, 2023 | 0 |
| Asgard Investment Corp. II | 10% Owner | 5,064,000Indirect | Aug 17, 2023 | 0 |
| Fletcher Aaron G.L. | Director | 143,470 | Dec 30, 2022 | 0 |
| Thurman Randy H | Director | 0 | Sep 30, 2022 | 0 |
| Mattes Glenn R. | President and CEO | 36,000 | May 17, 2022 | 0 |
| Cano Christopher | Chief Operating Officer | – | Sep 24, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 (view filing) | Sep 16 | Same day | Coleman Kirk AllenCFO, Secretary and Treasurer | PPurchase | +1.00K | $7.30 | +$7.30K | +100.0%2.00K after | |
| Sep 16, 2021 (view filing) | Sep 16 | Same day | Mattes Glenn R.President and CEO | PPurchase | +10.0K | $7.10 | +$71.0K | +100.0%20.0K after | |
| Apr 4, 2022 (view filing) | Apr 4 | Same day | Fletcher Aaron G.L.Director | PPurchase | +542.0K | $6.47 | +$3.50M | New position542.0K after | 2 lots |
| May 17, 2022 (view filing) | May 16 | 1 day | Rocamboli StephenDirector | PPurchase | +3.00K | $4.54 | +$13.6K | +19.1%18.7K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Mattes Glenn R.President and CEO | PPurchase | +16.0K | $4.78 | +$76.5K | +80.0%36.0K after | |
| May 17, 2022 (view filing) | May 16-17 | 1 day | Coleman Kirk AllenChief Financial Officer | PPurchase | +1.68K | $4.51 | +$7.55K | +83.8%3.67K after | 2 lots |
| May 17, 2022 (view filing) | May 16 | 1 day | Weisman Harlan FDirector | PPurchase | +2.50K | $4.74 | +$11.8K | +50.0%7.50K after | |
| May 17, 2022 (view filing) | May 16-17 | 1 day | Fletcher Aaron G.L.Director | PPurchase | +109.6K | $4.91 | +$538.1K | New position109.6K after | 2 lots |
| May 20, 2022 (view filing) | May 18-20 | 2 days | Weisman Harlan FDirector | PPurchase | +7.12K | $5.37 | +$38.2K | +94.9%14.6K after | 2 lots |
| Sep 30, 2022 (view filing) | Sep 29 | 1 day | Thurman Randy HDirector | SSale | −40.3K | $4.29 | −$172.7K | −100.0%0 after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Fletcher Aaron G.L.Director | PPurchase | +43.5K | $1.15 | +$50.0K | +43.5%143.5K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Fletcher Aaron G.L.Director | PPurchase | +21.7K | $0.00 | $0 | –21.7K after | Derivative |
| Dec 19, 2022 (view filing) | Dec 15 | 4 days | Weisman Harlan FPresident and CEO | PPurchase | +50.0K | $1.06 | +$53.0K | +342.1%64.6K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Mikhak ZamanehChief Medical Officer | PPurchase | +15.0K | $0.82 | +$12.3K | New position15.0K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Weisman Harlan FPresident and CEO | PPurchase | +150.0K | $0.88 | +$132.0K | +232.1%214.6K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Coleman Kirk AllenChief Financial Officer | PPurchase | +12.0K | $0.79 | +$9.48K | +326.5%15.7K after | |
| Mar 13, 2023 (view filing) | Mar 10 | 3 days | Rocamboli StephenDirector | PPurchase | +13.0K | $0.80 | +$10.4K | +433.3%16.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Mikhak ZamanehChief Medical Officer | PPurchase | +120.0K | $0.25 | +$30.0K | +800.0%135.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Mills Robert SDirector | PPurchase | +40.0K | $0.25 | +$10.0K | +250.3%56.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Coleman Kirk AllenChief Financial Officer | PPurchase | +20.0K | $0.25 | +$5.00K | +127.6%35.7K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Roberts BrandiDirector | PPurchase | +20.0K | $0.25 | +$5.00K | New position20.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Rocamboli StephenDirector | PPurchase | +20.0K | $0.25 | +$5.00K | +125.0%36.0K after | |
| Aug 15, 2023 (view filing)8:00 AM ET | Aug 15 | Same day | Weisman Harlan FPresident and CEO | PPurchase | +600.0K | $0.25 | +$150.0K | +279.6%814.6K after | |
| Aug 17, 2023 (view filing)5:29 PM ET | Aug 15 | 2 days | Carlson Capital, L.P. and 3 others10% Owner | SSaleCommon Stock, par value $0.001 per share (the "Common Stock" | −215.0K | $0.4374 | −$94.0K | −4.1%5.07M after | |
| Aug 17, 2023 (view filing)5:29 PM ET | Aug 16 | 1 day | Carlson Capital, L.P. and 3 others10% Owner | SSale | −1.00K | $0.3916 | −$391.6 | 0.0%5.06M after |